DELPHARM REIMS

As a major CDMO, #Delpharm is proud be among the first three PSCI - Pharmaceutical Supply Chain Initiative Supplier Partner. This shows Delpharm’s commitment to improve its global supply chain sustainability towards its clients and patients. “Delpharm believes that every company has a key role to play in making a difference and driving responsible value chain practices. Becoming a Supplier Partner demonstrates Delpharm’s commitment to drive excellence in safety, environmental, and social outcomes within our company and across the global pharmaceutical and healthcare supply chain.” Nicolas Ragot, Managing Director at Delpharm #CDMO #Sustainability #PSCI

[Meet Delpharm at CPhI Worldwide 2024] #Delpharm will be in CPhI Worldwide 2024 from October 8th to 10th, in Milan. We will be please to host you in our booth and to discuss your development and manufacturing projects. 𝐕𝐢𝐬𝐢𝐭 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐚𝐭 𝐛𝐨𝐨𝐭𝐡: 𝟓𝐂𝟏 📅 Book a meeting with our sales teams with your existing contact or through Delpharm website: https://lnkd.in/dwn_qsp #CPHIMilan #healthcare

𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐀𝐜𝐚𝐝𝐞𝐦𝐲 𝐬𝐚𝐭𝐢𝐬𝐟𝐢𝐞𝐬 𝐭𝐡𝐞 𝐆𝐫𝐨𝐮𝐩'𝐬 𝐞𝐦𝐩𝐥𝐨𝐲𝐞𝐞𝐬: "𝐀𝐧 𝐞𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥 𝐩𝐫𝐨𝐜𝐞𝐬𝐬 𝐟𝐨𝐫 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦” Since the beginning of 2024, Delpharm employees who had completed face-to-face training rated a global satisfaction rate of 4.7/5. 𝑊ℎ𝑎𝑡 𝑚𝑎𝑘𝑒𝑠 𝑡ℎ𝑒 𝐷𝑒𝑙𝑝ℎ𝑎𝑟𝑚 𝐴𝑐𝑎𝑑𝑒𝑚𝑦 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑡?  During training sessions, participants have the opportunity to exchange and meet colleagues from other site and to follow training tailored to their needs. #humanresources #Delpharm #pharmaceuticals

[Discover our HRMS capabilities] Combined with our expert’s knowledge, this cutting edge High Resolution Mass Spectrometer (HRMS) is revolutionizing structure elucidation, conformation analysis and mass spectrometry. 📄#CaseStudy: Are you curious about the real-world impact of our services? Take a look at our latest case study, where we helped customers in their structure analysis elucidation and therefore confirmed hypothesis regarding impurities, providing invaluable insights for their research and development efforts. Our expert’s precision and accuracy enabled them to make informed decisions and accelerate their projects to the next level. At #Delpharm, we are committed to delivering unparalleled analytical solutions tailored to your unique needs. Ready to unlock the power of HRMS for your projects. Reach us today to learn more at [email protected]! Here is the link to have access to the full case study: https://lnkd.in/es6dfnhZ #Innovation #Success 

For the World Thyroid Day on 25 May, Delpharm is reaffirming its commitment to patients suffering from thyroid-related diseases. #Delpharm is committed, in collaboration with its drug-owning customers, to combating hyperthyroidism by manufacturing treatments. Hyperthyroidism manifests itself as overactivity of the thyroid gland, causing an excessive release of thyroid hormones into the body. These hormones play a crucial role in regulating metabolism. Delpharm would like to thank DELPHARM TOURS and DELPHARM L'AIGLE for their involvement in the fight against thyroid disease and their contribution to improving the health and quality of life of sufferers. #WorldThyroidDay #healthcare #cdmo

🗓️ Save the Date ! #Delpharm is gearing up for CPhI North America 2024 in Philadelphia, happening from May 7th to 9th.   Our team is excited to engage with you and delve into discussions about your development and manufacturing projects. 💡🤝   Reach out to us through our website to schedule a meeting during the event : https://lnkd.in/dwn_qsp #CPHINA #CPHINorthAmerica

On 2 April, Delpharm finalized the acquisition from Astellas Pharma of the Meppel pharmaceutical manufacturing facility in the Netherlands. This site, fully equipped with state-of-the-art technologies, will be an additional asset for Delpharm in its production of solid dosage forms, with the possibility to export in the United States thanks to the FDA certification. Furthermore, it will strengthen Delpharm’s position in the Netherlands where the CDMO already owns one manufacturing site in Bladel and an injectable drug development centre in Leiden. For further information, please read the Delpharm press release: https://lnkd.in/eHqWCxyU #Delpharm #investing #strategy

[Prefilled syringes at Delpharm]   DELPHARM TOURS team is finalizing equipment qualification for the prefilled syringes line. Discover the dedicated workshop for your next prefilled syringes manufacturing and packaging projects. #Delpharm #Healthcare